Anna Teresa Palamara

Pubblicazioni

Titolo Pubblicato in Anno
NRF2 Antioxidant Response and Interferon‐Stimulated Genes Are Differentially Expressed in SARS‐CoV‐ 2‐Positive Young Subjects IMMUNITY, INFLAMMATION AND DISEASE 2025
Human neuroinvasive Toscana virus infections in Italy from 2016 to 2023. Increased incidence in 2022 and 2023 EUROSURVEILLANCE 2025
Chronic intestinal pseudo-obstruction: associations with gut microbiota and genes expression of intestinal serotonergic pathway BMC MICROBIOLOGY 2024
Effectiveness against severe COVID-19 of a seasonal booster dose of bivalent (original/Omicron BA.4-5) mRNA vaccines in persons aged ≥60 years: Estimates over calendar time and by time since administration during prevalent circulation of different Omicron subvariants, Italy, 2022–2023 VACCINE 2024
In vivo evolution to hypermucoviscosity and ceftazidime/avibactam resistance in a liver abscess caused by Klebsiella pneumoniae sequence type 512 MSPHERE 2024
Anisakis extracellular vesicles elicit immunomodulatory and potentially tumorigenic outcomes on human intestinal organoids PARASITES & VECTORS 2024
Acinetobacter baumannii OmpA-like porins: functional characterization of bacterial physiology, antibiotic-resistance, and virulence COMMUNICATIONS BIOLOGY 2024
HSV-1 infection induces phosphorylated tau propagation among neurons via extracellular vesicles MBIO 2024
A Serum Multi-Parametric Analysis Identifies an Early Innate Immune Signature Associated to Increased Vaccine-Specific Antibody Production and Seroconversion in Simultaneous COVID-19 mRNA and Cell-Based Quadrivalent Influenza Vaccination VACCINES 2024
Functional diversification of innate and inflammatory immune responses mediated by antibody fragment crystallizable activities against SARS-CoV-2 ISCIENCE 2024
SINGLE CELL MULTI-OMIC ANALYSIS OF THE INNATE IMMUNE COMPARTMENT REVEALS A SARS-CoV-2-SPECIFIC PHENOTYPE IN HUMAN MONOCYTES Frontiers in Microbiology 2024
Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 - February 2022) INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 2023
Influenza virus replication is affected by glutaredoxin1-mediated protein deglutathionylation THE FASEB JOURNAL 2023
Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production THE FASEB JOURNAL 2023
Insightful improvement in the design of potent uropathogenic E. coli fimh antagonists PHARMACEUTICS 2023
NRF2 Antioxidant Response and Interferon-Stimulated Genes Are Differentially Expressed in Respiratory-Syncytial-Virus- and Rhinovirus-Infected Hospitalized Children PATHOGENS 2023
Genetic diversity and its impact on disease severity in respiratory syncytial virus subtype-A and -B bronchiolitis before and after pandemic restrictions in Rome JOURNAL OF INFECTION 2023
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study THE LANCET INFECTIOUS DISEASES 2023
Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023 EUROSURVEILLANCE 2023
Atopic dermatitis-derived Staphylococcus aureus strains: what makes them special in the interplay with the host FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY 2023

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma